Angiotensin-TGF-&bgr;1 Crosstalk in Human Idiopathic Pulmonary Fibrosis:Autocrine Mechanisms in Myofibroblasts and Macrophages

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|12|1247-1256

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.12, 2007-04, pp. : 1247-1256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Mechanisms of and Possible Treatment Strategies for Idiopathic Pulmonary Fibrosis

By  

Current Pharmaceutical Design, Vol. 11, Iss. 30, 2005-11 ,pp. : 3943-3971

Bentham Science Publishers

Access to resources Recommend Favorite

Pirfenidone: In Idiopathic Pulmonary Fibrosis

By Carter Natalie J.  

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1721-1732

Adis International

Access to resources Recommend Favorite

Interferon-&ggr; 1b: impact of new indications (idiopathic pulmonary fibrosis)

By Aggarwal A.N.   Behera D.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 7, 2000-12 ,pp. : 1423-1427

Informa Healthcare

Access to resources Recommend Favorite

Cytokines and Invertebrates: TGF-&bgr; and PDGF

By  

Current Pharmaceutical Design, Vol. 12, Iss. 24, 2006-08 ,pp. : 3025-3031

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of the TGF-&bgr; Superfamily and their Clinical Applications

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-11 ,pp. : 1255-1261

Bentham Science Publishers

Access to resources Recommend Favorite